↓ Skip to main content

Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection

Overview of attention for article published in PLOS ONE, February 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

blogs
1 blog
patent
7 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
141 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
Published in
PLOS ONE, February 2010
DOI 10.1371/journal.pone.0009390
Pubmed ID
Authors

Nancie M. Archin, Manzoor Cheema, Daniel Parker, Ann Wiegand, Ronald J. Bosch, John M. Coffin, Joseph Eron, Myron Cohen, David M. Margolis

Abstract

Human immunodeficiency virus (HIV) infection that persists despite antiretroviral therapy (ART) is a daunting problem. Given the limited evidence that resting CD4+ T cell infection (RCI) is affected by the histone deacetylase (HDAC) inhibitor valproic acid (VPA), we measured the stability of RCI and residual viremia in patients who added VPA with or without raltegravir (RAL), or enfuvirtide (ENF) with or without VPA, to standard ART.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 4%
Portugal 1 <1%
Australia 1 <1%
Argentina 1 <1%
Brazil 1 <1%
Spain 1 <1%
Denmark 1 <1%
Unknown 100 91%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 27%
Researcher 17 15%
Student > Master 11 10%
Student > Bachelor 8 7%
Other 7 6%
Other 21 19%
Unknown 16 15%
Readers by discipline Count As %
Medicine and Dentistry 33 30%
Agricultural and Biological Sciences 28 25%
Immunology and Microbiology 11 10%
Biochemistry, Genetics and Molecular Biology 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 7 6%
Unknown 21 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#2,685,359
of 22,788,370 outputs
Outputs from PLOS ONE
#34,336
of 194,531 outputs
Outputs of similar age
#10,720
of 93,802 outputs
Outputs of similar age from PLOS ONE
#148
of 665 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 194,531 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,802 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 665 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.